Sphingolipid profiling as a biomarker of type 2 diabetes risk: evidence from the MIDUS and PREDIMED studies
2024

Sphingolipid Profiling as a Biomarker for Type 2 Diabetes Risk

Sample size: 2072 publication 10 minutes Evidence: moderate

Author Information

Author(s): Loni Berkowitz, Cristina Razquin, Cristian Salazar, Fiorella Biancardi, Ramón Estruch, Emilio Ros, Montserrat Fitó, Dolores Corella, Christopher L. Coe, Carol D. Ryff, Miguel Ruiz-Canela, Jordi Salas-Salvadó, Daniel Wang, Frank B. Hu, Amy Deik, Miguel A. Martínez-Gonzalez, Attilio Rigotti

Primary Institution: Pontificia Universidad Católica of Chile

Hypothesis

The study aims to characterize the associations between blood glycosphingolipid and ceramide species with type 2 diabetes (T2D) and to identify a circulating sphingolipid profile that could serve as a novel biomarker for T2D risk.

Conclusion

The study supports the potential usefulness of circulating sphingolipid profiles as novel biomarkers for T2D risk.

Supporting Evidence

  • Only CER18:0 and CER22:0 were linked to insulin resistance and higher prevalence of T2D.
  • Three lactosylceramides showed a strong inverse relationship with both insulin resistance and T2D.
  • The sphingolipid scores predicted a reduced risk of T2D incidence in PREDIMED.
  • 5-year absolute risk differences were 9.6% and 11.4% lower for the highest quartiles of sphingolipid scores.

Takeaway

This study found that certain fats in the blood can help predict if someone might get type 2 diabetes, which is a serious health problem.

Methodology

The study used a cross-sectional analysis of sphingolipid levels in 2,072 American adults and a prospective case-cohort design within the PREDIMED trial with 250 cases and 692 participants over 3.8 years.

Potential Biases

Potential bias due to the exclusion of certain participants and the reliance on self-reported data for demographics.

Limitations

The observational nature of the study limits causal inferences, and there may be unmeasured confounding variables.

Participant Demographics

54.7% females, 74.9% Whites of European family backgrounds, average age 55.6 years.

Statistical Information

P-Value

0.024

Confidence Interval

95% CI 0.44 to 0.94

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1186/s12933-024-02505-7

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication